Standard Operating Procedure for Regulatory Submission Handover Between Teams
| Department | Regulatory Affairs |
| SOP No. | RA/2026/609 |
| Supersedes | NA |
| Page No. | 1 of X |
| Issue Date | 07/04/2026 |
| Effective Date | 07/04/2026 |
| Review Date | 07/04/2028 |
Purpose
This Standard Operating Procedure (SOP) defines a controlled and consistent process for the effective handover of regulatory submissions between teams within the organization. The purpose is to ensure uninterrupted workflow, maintain submission integrity, ensure compliance with applicable regulatory requirements, facilitate clear communication, and safeguard complete and accurate documentation throughout the regulatory submission lifecycle. This SOP supports the quality objective of seamless collaboration and regulatory compliance during transition phases.
Scope
This SOP applies to all regulatory affairs personnel and associated departments involved in the preparation, review, approval, and submission of regulatory dossiers for any product, dosage form, or regulatory filing type. It encompasses all stages and formats of regulatory submissions being transferred between functional teams, including but not limited to, initial compilation, internal review, external submission, and post-submission follow-up. Activities outside regulatory submission handovers, such as unrelated administrative transfers, are excluded.
Responsibilities
– Regulatory Affairs Submitting Team: Responsible for preparing all necessary submission documentation and information for handover.
– Receiving Regulatory Team: Responsible for reviewing and acknowledging receipt of submission documentation, ensuring completeness.
– Regulatory Affairs Manager: Supervises handover activities ensuring compliance to timelines and SOP adherence.
– Quality Assurance: Oversees compliance audits and verification of documentation during handover.
– Documentation Control: Manages version control and record retention of submission documents.
– Training Coordinator: Ensures involved personnel are trained on this SOP and applicable procedures.
Accountability
The Regulatory Affairs Head is accountable for the effective implementation, compliance monitoring, periodic review, escalation of issues, and ensuring the ongoing suitability and effectiveness of this SOP within the organization’s regulatory operations.
Procedure
1. Preparation for Handover:
The Submitting Team shall compile the complete set of submission documents including regulatory dossiers, supporting data, correspondence, and internal approvals. Documents must be organized, clearly labeled, and validated for accuracy and version control according to GMP and regulatory standards.
2. Prerequisites and Checks:
Confirm all required documentation is finalized and appropriately authorized. Verify no outstanding queries or discrepancies exist. All materials should comply with the regulatory authority’s format and submission guidelines.
3. Handover Execution:
The Submitting Team formally initiates the handover by providing submission packages to the Receiving Team via designated secure methods (e.g., secured electronic transfer or controlled physical delivery). A formal handover notification must be documented specifying submission details, version numbers, and any critical points of attention.
4. Acknowledgment and Verification:
The Receiving Team shall review received materials promptly to confirm completeness and accuracy. Any discrepancies or missing elements must be immediately reported back to the Submitting Team for corrective action.
5. Documentation and Record-Keeping:
All handover forms, tracking logs, and communications shall be documented and maintained per company policy and regulatory record retention requirements. Changes or deviations encountered during handover must be recorded, investigated, and managed appropriately.
6. Approvals and Escalation:
Ensure all handover steps are approved by designated responsible personnel. Any significant delays, issues, or non-compliances must be escalated to the Regulatory Affairs Manager and QA for prompt resolution.
7. Closure:
Once all handover activities are satisfactorily completed and verified, formal closure is documented, and parties confirm readiness to proceed with the subsequent submission phases.
Following this controlled approach ensures regulatory submissions are managed consistently, risks are minimized, and compliance with internal and external standards is maintained throughout team transitions.
Abbreviations
GMP: Good Manufacturing Practice
QA: Quality Assurance
RA: Regulatory Affairs
SOP: Standard Operating Procedure
PIF: Product Information File
Documents
- Regulatory Submission Handover Form (Annexure-1)
- Submission Document Checklist (Annexure-2)
- Handover Acknowledgment Log (Annexure-3)
References
– ICH Q10 Pharmaceutical Quality System
– FDA Guidance for Industry: Common Technical Document
– EMA Guideline on the Requirements for Quality Documentation
– Company Quality Management System Manual
– Applicable regulatory authority submission guidelines and formats
Version
1.0
Approval
| Prepared By | |
| Checked By | |
| Approved By |
Annexures
Annexure-1: Regulatory Submission Handover Form
Purpose: To formally document the details of the regulatory submission handover between teams, ensuring clarity and traceability.
| Submission Title | New Drug Application – Module 3 |
| Submission Number | NDA-2026-001 |
| Submitting Team | Regulatory Compilation Group |
| Receiving Team | Regulatory Review Group |
| Date of Handover | 07/04/2026 |
| Version Number of Submission Documents | v1.2 |
| Special Instructions / Notes | Ensure inclusion of updated stability data before next phase |
| Submitting Team Lead Signature | ________________________ |
| Receiving Team Lead Signature | ________________________ |
Annexure-2: Submission Document Checklist
Purpose: To verify completeness and accuracy of all documents included in the regulatory submission handover package.
| Document Name | Included (Yes/No) | Version | Comments |
|---|---|---|---|
| Cover Letter | Yes | v1.0 | – |
| Module 1 Administrative Info | Yes | v1.1 | – |
| Module 2 Overview | Yes | v1.2 | – |
| Module 3 Quality | Yes | v1.2 | Includes updated stability report |
| Module 4 Nonclinical | Yes | v1.0 | – |
| Module 5 Clinical | No | – | Pending final update |
Annexure-3: Handover Acknowledgment Log
Purpose: To track and confirm all submission handovers completed between teams, including date, submission details, and acknowledgments.
| Date of Handover | Submission Title | Submitting Team | Receiving Team | Acknowledgment Received | Comments |
|---|---|---|---|---|---|
| 07/04/2026 | New Drug Application – Module 3 | Regulatory Compilation Group | Regulatory Review Group | Yes | No discrepancies reported |
| 05/02/2026 | Clinical Trial Application | Clinical Regulatory Team | Submission Support Team | Yes | Minor formatting correction requested |
Revision History
| Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
| 07/04/2026 | 1.0 | Initial issue | New SOP creation |